Abstract:Objectives: Interleukin-27 (IL-27) is known as an anti-HIV cytokine. We have recently demonstrated that IL-27-pretreatment promotes phytohemagglutinin-stimulated CD4(+) T cells into HIV-1-resistant cells by inhibiting an uncoating step. Purpose: To further characterize the function of the HIV resistant T cells, we investigated profiles of microRNA in the cells using microRNA sequencing (miRNA-seq) and assessed anti-HIV effect of the microRNAs. Methods: Phytohemagglutinin-stimulated CD4(+) T cells were treated with or without IL-27 for 3 days. MicroRNA profiles were analyzed using miRNA-seq. To assess anti-HIV effect, T cells or macrophages were transfected with synthesized microRNA mimics and then infected with HIVNL4.3 or HIVAD8. Anti-HIV effect was monitored by a p24 antigen enzyme-linked immunosorbent assay kit. interferon (IFN)-α, IFN-β, or IFN-λ production was quantified using each subtype-specific enzyme-linked immunosorbent assay kit. Results: A comparative analysis of microRNA profiles indicated that expression of known miRNAs was not significantly changed in IL-27-treated cells compared with untreated T cells; however, a total of 15 novel microRNAs (miRTC1 ∼ miRTC15) were identified. Anti-HIV assay using overexpression of each novel microRNA revealed that 10 nM miRTC14 (GenBank accession number: MF281439) remarkably suppressed HIV infection by (99.3 ± 0.27%, n = 9) in macrophages but not in T cells. The inhibition was associated through induction of >1000 pg/mL of IFN-αs and IFN-λ1. Conclusion: We discovered a total of 15 novel microRNAs in T cells and characterized that miRTC14, one of the novel microRNAs, was a potent IFN-inducing anti-HIV miRNA, implicating that regulation of the expression of miRTC14 may be a potent therapeutic tool for not only HIV but also other virus infection.

The impact of microRNAs on human immunodeficiency virus infection: A flying bullet to invader?

Identify Potential Regulators in Hiv-1 Latency by Joint Microrna and Mrna Analysis

miRNAs and human immunodeficiency virus type 1 infection:biomarkers and antiviral therapy

Critical Role of Micrornas in Host and Influenza A (H1N1) Virus Interactions.

Biological function of microRNA in HIV-1 infection:summary of recent progress

Progress of the Stady on Microrna in Regulating Innate Immunity

High-throughput Sequencing Identifies HIV-1-replication- and Latency-Related Mirnas in CD4+ T Cell Lines.

The Role of MicroRNAs in HIV Infection

Two Cellular Micrornas, Mir-196B and Mir-1290, Contribute to HIV-1 Latency

MicroRNAs and exosomes: key players in HIV pathogenesis

Hsa-Mir-181-5p Inhibits Human Immunodeficiency Virus Type 1 Replication by Downregulating DDX3X Expression.

The Molecular Mechanisms of microRNA Regulating Innate Immune Response

MicroRNA-181 Expression Regulates Specific Post-Transcriptional Level of SAMHD1 Expression in Vitro.

siRNA, miRNA and HIV: promises and challenges

The Role of HIV-1-Encoded microRNAs in Viral Replication

One microRNA has the potential to target whole viral mRNAs in a given human coronavirus

MicroRNAs and long non-coding RNAs during transcriptional regulation and latency of HIV and HTLV

Human and Viral microRNA Expression in Acute and Chronic HIV Infections

microRNA-guided immunity against respiratory virus infection in human and mouse lung cells

Profiles of MicroRNAs in Interleukin-27-Induced HIV-Resistant T Cells: Identification of a Novel Antiviral MicroRNA

Altered Host microRNAomics in HIV Infections: Therapeutic Potentials and Limitations